Front Endocrinol (Lausanne) 14(12):735824 [DOI] [PMC free article] [PubMed] [Google Scholar] 78.Cheng L, Hu Y, Li YY, Cao X, Bai N, Lu TT, Li GQ, Li N, Wang AN, Mao XM (2019) Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Additionally, millions around the world have started using these medications to assist in [their] weight loss goals. This is not the first research to examine a link between the use of GLP-1 agonists and potential gastrointestinal problems
These medications slow stomach emptying, reduce appetite signals in the brain, and improve how your body manages blood glucose
All customers are assumed and expected to be qualified researchers
Pomegranate ($119/mo flat for every dose up to 2.5mg)